Tirzepatide vs. Semaglutide, Parkinson's Cognitive Symptoms, and Canadian Dental Care Updates

In today's episode, Dr. Chi-Ming Chow discusses a study comparing tirzepatide and semaglutide for weight loss, including key takeaways and cohort details. He also covers the approval status of these medications. The episode explores cognitive symptoms in Parkinson's disease and how machine learning aids in understanding these symptoms, as well as the link between depression and cognitive issues in Parkinson's. Updates on the Canadian Dental Care Plan and strategies for managing children's social media use during summer are also featured.